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ABSTRACT
Reactions ofthe complexes bisethylendiammine gold(Ill) and bisethylendiammine platinum(II) with
calfthymus DNA were comparatively analysed. Both complexes bind DNA non-covalently most probably on
the basis of electrostatic interactions. Binding of either complex at low ratios results into modest
modifications ofB-type DNA conformations, as detected by CD. Far larger CD alterations are observed at
high ratios. The gold(Ill) chromophore is scarcely perturbed by DNA addition Binding of [Au(en)z]C13 to calf
thymus DNA is reversed by sodium cyanide. By analogy with the case of [Pt(en)2]C12 it is suggested that
Auen acts as a minor groove binder.
INTRODUCTION
There is considerable interest in evaluating non-covalent interactions oftransition metal complexes
to DNA since the detailed knowledge ofthese interactions may contribute to elucidate the mechanisms of
metal-DNA recognition 1,2]. For example extensive work has been carried out on binding ofthe cations
hexammine cobalt(Ill) and tris ethylendiarnine cobalt(Ill) to DNA; both complexes were shown to be very
effective in recognizing specific DNA sequences and in modifying DNA conformation through formation of
electrostatic and hydrogen bond interactions [3-5]. The non-covalent interactions ofseveral ruthenium
complexes with DNA and with synthetic oligonucleotides have been investigated in detail by Barton and by
other groups [6-8]. Recently, Collins et al reported on the reaction of [Pt(en)2]Cl with the DNA dodecamer
d(CAATCCGGATTG), and demonstrated, by high resolution 1HNMR spectroscopy, that this complex
binds non-covalently the oligonucleotide in the minor groove at AT rich regions [9].
In the last years we have been working on the development, the characterization and the
pharmacological evaluationofgold(lll) complexes as potential antitumor agents [10-12]; among the
investigated compounds, the cationic square planar bisethylendiamine gold(Ill) complex ([Au(en)z]Cl3
hereaRer; scheme I) showed favorable cytotoxic properties toward the A2780 human ovarian cancer cell line
[2].
Scheme I
H
Schematic drawil2ng ofthe [Au(en)2Cl3 complex
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Since the [Au(en)2]Cl3 complex is water soluble and fairly stable under physiological conditions we
investigated in more detail its interactions in vitro with DNA, the probable target for several antitumor metal
complexes 13]. Given the fact that [Au(en)2]Cl3 is isoelectronic and isostructural with [Pt(en)2]Cl2, it is
reasonable to hypothesize that its interaction with DNA may reproduce the main features of the
[Pt(en)2]CI2/DNA interaction. With this in mind we followed the reaction of [Au(en)2]Cl3 with calfthymus
DNA through various spectroscopic techniques such as spectrophotometry, circular dichroism and analysis of
DNA melting profiles; for comparison purposes similar experiments were carried out on the parent compound
bisethylendiamine platinum(II) dichloride.
MATERIALS AND METHODS
[Au(en)2]Cl was synthesized as reported in literature 12]. The purity ofthe compound was checked
through elemental analysis and 1HNMR spectroscopy. [Pt(en)2]Cl2 and Calfthymus DNA were purchased
from Sigma Chemical Company. All other reagents used in this study were of analytical grade and were
commercially available.
Electronic absorption spectra were measured with a Perkin Elmer Lambda 20 Bio instrument.
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Electronic spectra of [Au(en)2]C12x10
-4M were recorded before and after addition ofcalfthymus
DNA (r 0.2) in the phosphate 50 mM, NaCI 4 mM, pH 7.4 buffer.
All melting measurements were carried out in the 10"-M NaC104 and 10
.3 M NaCI buffer. Calf
thymus DNA was dissolved in the buffer and DNA concentration determined by absorption measurements at
260 nm. DNA concentration was equal to 3.6xl0
-5M [nucleotide]. DNA was treated with [Au(en)2]C13 or
[Pt(en)z]Cb at mol/bp ratios r 0.1, and each sample was incubated for hour at room temperature.
Thermal denaturation experiments were performed in quartz cuvettes with a Perkin Elmer Lamba 20
Bio spectrophotometer equipped with a thermostated cell as described in reference. Samples were
continuously heated with a rate oftemperature increase of0.5C/min while monitoring the absorbance
changes at 260 nm. The investigated interval oftemperature ranged from 50C to 90C. Upon reaching
90C, samples were cooled back to 40C in order to follow the renaturation process. Values for melting
temperatures (Tm) and for the melting interval (AT) were determined according to the reported procedures
[14].
CD spectra were recorded at increasing complexthymus DNA ratio after mixing on a Jasco J600
dichrograph operating at room temperature, interfaced with a PC, and analyzed through the standard Jasco
software package; either [Au(en)]Cl3 or [Pt(en)z]Clz were added at the ratios r=0.1, r=0.2, r=0.5, r 1.0,
r=2.0, r=4.0, r=10.0. DNA concentration (expressed in basepair) was 8.9x10SM in buffer phosphate 50mM,
NaC1 4 mM, pH=7.4. The CD technique is indeed very sensitive to even minor conformational changes of
the DNA conformation produced by ligand binding 15].
RESULTS AND DISCUSSION
The reaction ofthe bisethylenediamine gold(III) complex with calfthymus DNA was first analyzed
through absorption spectroscopy. It is observed that addition of saturating amounts of calfthymus DNA to a
buffered solution containing [Au(en)2]Cl3 does not alter the characteristic charge transfer bands ofthe
[Au(en)z]Cl complex (Figure 1). This means that addition of calfthymus DNA does not produce any major
perturbation ofthe gold(III) ehromophore.
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Figure 1. Absorption electronic spectra of [Au(en)2]Cl3 before (a) and after addition (b) ofa saturating
amount of calfthymus DNA.
To establish in more detail whether binding of [Au(en)2]Cl3 brings about any significant
conformational change ofthe DNA double helix CD spectra of calfthymus DNA were carried out at
increasing [Au(en)2]C13 to calfthymus DNA ratios. The profile ofthe CD titration of calfthymus DNA with
[Au(en)2]C13 is shown in Figure 2.
Upon addition of small amounts of [Au(en)2]Cl3, minor changes ofthe B-type CD spectrum of calf
thymus DNA are observed that reach completion at r 0.1; for higher gold to DNA ratios more important
changes ofthe CD spectnma are detected that are diagnostic of larger conformational changes. Remarkably
addition of excess sodium cyanide causes complete reversal ofthe CD effects implying that the observed
changes are a direct consequence of [Au(en)2]Cl3 binding and that they are reversible upon gold removal. For
comparison purposes a CD titration of calfthymus DNA with [Pt(en)2]Cl2 was carried out under the same
experimental conditions; the resulting spectral profiles are shown in Figure 3.
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Figure 2 CD titration of calfthymus DNA with increasing amounts of the biscthylcndiamine gold(HI)
complexes. [Au(cn)2]C13 was added at the following ratios: r=0.1, r=0.2, r=0.5, r .0, r=2.0, r=4.0, r 0.0
(from top to the bottom on the positive band at 260 nm and the reversal on the negative band at 240 nm).
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Figure 3 CD titration of calfthymus DNA with increasing amounts of the bisethylendiamine platinum(II)
complexes. [Pt(en)2]C12 was added at the following ratios: r=0.1, r=0.2, r=0.5, r 1.0, r=2.0, r=4.0, r 10.0
(from top to the bottom on the positive band at 260 nm and the reversal on the negative band at 240 nm).
From inspection ofthe spectra it is apparent that [Pt(en)2]Cl2 produces effects that are very similar,
but not identical, to those produced by [Au(en)2]Cl. Again a biphasic behaviour is observed implying
occurrence ofboth high affinity and low affinity binding of [Pt(en)2]C12 to DNA.
Finally, the effects ofbinding ofboth [Au(en)2]Cl3 and [Pt(en)2]Cl2 on the stability ofDNA double
helix were investigated through analysis of the helix-to-coil transition. It is found that addition of
[Au(en)2]C13, at r=0.1, results into a modest increase of the melting temperature (Tm) with ATmI.0C; a
similar effect is produced by the addition of equimolar amounts of [Pt(en)2]C12 (ATm-=0.6C). Again these
data imply a similar mode of interaction.
CONCLUSIONS
In conclusion the present results show that the cytotoxic complex [Au(en)2]Cl3, that is fairly stable
under physiological conditions, binds calfthymus DNA non covalently with an affinity constant comparable
to that of [Pt(en)2]Clz. The interaction is electrostatic in nature and reversible, and brings about a modest
conformational change and a slight stabilization ofthe double helix. Given the strict structural relationship of
[Au(en)2]Cl3 to [Pt(en)2]Cl2 and the similar profile ofthe CD titrations it is suggested that [Au(en)2]C13 binds
DNA in a similar fashion to [Pt(en)2]Cl2. According to the model proposed by Collins et al. such interaction
should occur through minor groove binding ofthe cationic gold(Ill) complex, in correspondence ofAT rich
regions.
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